Vaccines for Adults

Closed Solicitation Posted

Solicitation number
75D30125R00097
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) is seeking to award one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for standard commercial adult vaccines under Section 317 of the Public Health Service Act. The solicitation aims to purchase vaccines for state and local health departments, targeting populations at greatest risk for under vaccination. The contract will cover 17 different vaccine types, including Hepatitis A/B, HPV, MMR, Meningococcal, Pneumococcal, and Tdap vaccines. Proposals must be submitted electronically by May 1, 2025, at 1:00 PM EST, with evaluation criteria focusing on FDA licensing compliance, shelf-life requirements, federal excise tax provisions, and past performance. Technical and pricing proposals will be carefully reviewed to ensure they meet the CDC's specific immunization program needs.

The solicitation encourages submissions from small businesses, with specific subcontracting goals including 12.17% for small businesses, 9.5% for small disadvantaged businesses, 1.61% for HUBZone businesses, 2.3% for women-owned small businesses, and 2.62% for service-disabled veteran-owned small businesses. The contract period will run from July 1, 2025, to June 30, 2026, with a 15-working-day delivery requirement after order receipt. Vaccine order quantities will range from 10 to 1,000,000 doses, with a minimum 12-month shelf life requirement. Delivery will be made to CDC distribution centers in Olive Branch, MS, and Clermont, KY. The program will support immunization efforts for fifty state health departments, several large city programs, and current and former U.S. Territories, with the primary performance location in Atlanta, GA.

Notice text

The Centers for Disease Control and Prevention (CDC) intends to award one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. The establishment of these contracts provides an opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease.
The 317 program, as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease's (NCIRD’s) immunization Awardees (the fifty state health departments, several large city programs and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.

Files

File Type Posted
A19. Solictation 75D30125R00097.pdf PDF
A19. RFP VFA 2025 pg. 2-57.docx DOCX document
A19. Attachment 02 ADR Agreement.docx DOCX document
A19. Attachment 01 List of Adult Vaccines.docx DOCX document
A19. Attachment 03 List of Products.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside
Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032 Atlanta, Georgia 30341, United States · NAICS 541690 CDC Office of Acquisition Services Partial Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity